Volpara Health Technologies (VHT) Stock Price, News & Analysis

Company Overview

Volpara Health Technologies Limited provides breast imaging analytics software products in New Zealand. The company offers Volpara Analytics, a software that optimize breast cancer screening operations; Volpara Live, which provides instant patient-based image quality feedback; Volpara Lung, a patient management software that streamlines lung screening workflow; and Volpara Patient Hub, a customizable mammography reporting and patient communications software. It also offers Volpara Risk, an integration with Patient Hub that uses TC8 to calculate patients' risk of developing breast cancer; Volpara Risk Pathways, a program for identifying and managing high-risk breast, lung, ovarian, and colorectal cancer screening patients; Volpara Scorecard, which displays patient breast density and risk insights essential for improved clinical decision-making and early detection; and Volpara Science, an AI-based software that powers Volpara software products; and Volpara Thumbnail, an image-enhanced patient notification letters. In addition, the company provides TruDensity, a Volpara clinical function; TruPGMI, a Volpara clinical function, which uses artificial intelligence to automatically and objectively assess the positioning of the patient and resulting image quality; TruPressure, a Volpara clinical function, which determines whether the compression pressure applied by the radiographer is in the sweet spot that yields quality images, minimal radiation exposure, and the least discomfort; and TruRadDose, a Volpara clinical function which analyses the radiation dose delivered to patients based on their breast density. It operates in North America, the Asia Pacific, Europe, the Middle East, and Africa. Volpara Health Technologies Limited has a strategic relationship with RevealDx. The company was incorporated in 2009 and is headquartered in Wellington, New Zealand.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 434,964 shs
• Average Volume: N/A
• Market Capitalization: A$291.26 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

VHT Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Volpara Health Technologies own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Volpara Health Technologies investors own include Fulgent Genetics (FLGT), Lockheed Martin (LMT), Boston Omaha (BOMN), CrowdStrike (CRWD), Netflix (NFLX),

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Medical
• Industry: Health Information Services
• Sub-Industry: N/A
• Current Symbol: ASX:VHT
• CIK: N/A
• Web: volparasolutions.com
• Phone: 64 4 499 6029
• Fax: N/A
• Employees: 156
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): A($0.04)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -A$8.92 million
• Net Margins: -27.99%
• Pretax Margin: N/A
• Return on Equity: -17.60%
• Return on Assets: -7.72%

Debt

• Debt-to-Equity Ratio: 4.06
• Current Ratio: 0.95
• Quick Ratio: 0.99

Sales & Book Value

• Annual Sales: A$37.96 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: A$0.19 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 254,370,000
• Free Float: N/A
• Market Cap: A$291.26 million
• Optionable: Not Optionable
• Beta: 1.67